Neoadjuvant Chemotherapy in Non Small Cell Lung Cancer (NSCLC) Stages IB, IIA, IIB, and IIIA/T3

NCT00273507 · clinicaltrials.gov ↗

PHASE3

Phase

TERMINATED

Status

270

Enrollment

OTHER

Sponsor class

Conditions

Non-small Cell Lung Cancer

Interventions

DRUG: Carboplatin and Paclitaxel

Sponsor

Rigshospitalet, Denmark